Verzenio now approved

Verzenio is a prescription medicine used:

  • In combination with fulvestrant to treat women with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic), whose disease has progressed after hormonal therapy.
  • Alone to treat adults with HR–positive, HER2–negative advanced breast cancer or metastatic breast cancer whose disease has progressed after hormonal therapy and prior chemotherapy.

Questions About Verzenio? Call:
1-844-VERZENIO (1-844-837-9364)

Verzenio Savings Card

Verzenio savings card icon

Eligible patients get the first 3 months of Verzenio FREE*†

Then pay no more than $10 a month for your Verzenio prescription.*†

Need a
Savings Card?

Already have a
Savings Card?

To download a Savings Card or to email it to yourself, just answer the following eligibility questions. Then your card will be ready to be shared with your specialty pharmacy

Artboard 1

Download now or get your Savings Card via email.

  • or

Present the Verzenio Savings Card to your pharmacist and pay no more than $10 a month over a 12-month enrollment period.*† The savings may have already been applied to the cost of Verzenio, but if you are unsure or have any questions about eligibility requirements, you can always call 1-844-VERZENIO (1-844-837-9364) Monday-Friday from 8 am to 10 pm Eastern Time.

To activate a Savings Card, just answer the following eligibility questions. Then your card will be ready to be shared with your specialty pharmacy.

Present the Verzenio Savings Card to your pharmacist and pay no more than $10 a month over a 12-month enrollment period.*† The savings may have already been applied to the cost of Verzenio, but if you are unsure or have any questions about eligibility requirements, you can always call 1-844-VERZENIO (1-844-837-9364) Monday-Friday from 8 am to 10 pm Eastern Time.

*If eligible, you can use your Verzenio Savings Card to cover the remaining out-of-pocket costs for commercial insurance plans, up to a maximum of $25,000 per year. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims for Verzenio are eligible to be reimbursed, in whole or in part, by any governmental program. Offer may be subject to a monthly and annual cap of wholesale acquisition cost plus usual and customary pharmacy charges.

†Eligibility Criteria

Verzenio Continuous Care

Personalized care that's here for you

We created the Verzenio Continuous Care program to give you personalized support and to help you have a positive experience while taking Verzenio. Your Verzenio Continuous Care Team* will serve as your dedicated partner throughout every stage of your treatment.

Verzenio Continuous Care logo

Through 1-on-1 check-ins, your Verzenio Continuous Care Team can support you by:

  • Navigating you through the insurance process
  • Identifying savings opportunities
  • Helping you understand what to expect with Verzenio
  • Answering questions you may have about Verzenio

Call 1-844-VERZENIO (1-844-837-9364) to learn more about Verzenio Continuous Care.

*The Verzenio Continuous Care Team is not made up of medical professionals. Your doctor is your source for medical advice.

Indication

Verzenio is a prescription medicine used:

  • In combination with fulvestrant to treat women with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic), whose disease has progressed after hormonal therapy.
  • Alone to treat adults with HR–positive, HER2–negative advanced breast cancer or metastatic breast cancer whose disease has progressed after hormonal therapy and prior chemotherapy.

Important Safety Information

Verzenio may cause serious side effects, including:

Diarrhea. Diarrhea is common with Verzenio and may sometimes be severe. Diarrhea may cause you to develop dehydration or infection. The most common time to develop diarrhea is during the first month of Verzenio treatment. Your doctor may stop your treatment, lower your dose, or tell you to wait to begin your treatment cycle if you have diarrhea.

  • At the first sign of loose stools, tell your doctor. You may be advised to start taking an antidiarrheal medicine (such as loperamide) and drink more fluids

Low white blood cell counts (neutropenia). Low white blood cell counts are common when taking Verzenio and may cause serious infections that can lead to death. Your doctor should check your white blood cell counts before and during treatment.

If you develop low white blood cell counts during treatment with Verzenio, your doctor may stop your treatment, decrease your dose, or may tell you to wait to begin your treatment cycle. Tell your doctor right away if you have signs and symptoms of low white blood cell counts or infections, such as fever and chills.

Liver problems. Your doctor should do blood tests before and during treatment to check your liver. Your doctor may stop your treatment, decrease your dose, or may tell you to wait to begin your treatment cycle if you develop liver problems. Tell your doctor right away if you have any of the following:

  • Feeling very tired
  • Pain on the upper right side of your stomach area (abdomen)
  • Loss of appetite
  • Bleeding or bruising more easily than normal

Blood clots in your veins or in the arteries of your lungs. Verzenio may cause serious blood clots that have led to death. Talk to your doctor if you have the following signs and symptoms of a blood clot:

  • Pain or swelling in your arms or legs
  • Shortness of breath
  • Chest pain
  • Fast breathing
  • Fast heart rate

Verzenio can harm your unborn baby. If you are able to become pregnant, you should use effective birth control during treatment with Verzenio and for at least 3 weeks after the last dose of Verzenio. Verzenio may affect the ability of males to father a child.

What are the possible side effects of Verzenio?

The most common side effects of Verzenio include: Nausea, infections, decreased appetite, headache, abdominal pain, tiredness and vomiting.

The most common changes to blood tests were low red blood cell count (anemia), low white blood cell counts (leukopenia) and low platelet count (thrombocytopenia).

You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

What should I tell my doctor before taking Verzenio?

Tell your doctor if you:

  • are pregnant or plan to become pregnant. If you become pregnant during your treatment, discuss this with your doctor.
  • are breastfeeding or plan to breastfeed. It is not known if Verzenio passes into your breast milk. Do not breastfeed during treatment with Verzenio and for at least 3 weeks after your last dose. You and your doctor should decide if you will take Verzenio or breastfeed. You should not do both.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Verzenio and certain other medicines can affect each other, causing serious side effects and may require you to change your dose. Especially tell your doctor if you take a medicine that contains ketoconazole. Avoid grapefruit products while taking Verzenio. Grapefruit may increase the amount of Verzenio in your blood.

Verzenio is available by prescription only.

Please see Safety Summary for Verzenio.

AL DTC ISI 02OCT2017